Related references
Note: Only part of the references are listed.The Metabonomic Signature of Celiac Disease
Ivano Bertini et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Arun Sreekumar et al.
NATURE (2009)
Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features
Lori J. Goldstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Metabolite profiling of human colon carcinoma - deregulation of TCA cycle and amino acid turnover
Carsten Denkert et al.
MOLECULAR CANCER (2008)
Assessment of PLSDA cross validation
Johan A. Westerhuis et al.
METABOLOMICS (2008)
Evidence of different metabolic phenotypes in humans
Michael Assfalg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer
Lyndsay Harris et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
[Anonymous]
JOURNAL OF ONCOLOGY PRACTICE (2007)
Metabolomics: Available results, current research projects in breast cancer, and future applications
Wederson Marcos Claudino et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A comprehensive urinary metabolomic approach for identifying kidney cancer
Tobias Kind et al.
ANALYTICAL BIOCHEMISTRY (2007)
HMDB: the human metabolome database
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2007)
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer
Marc Buyse et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival
Daniel F. Hayes et al.
CLINICAL CANCER RESEARCH (2006)
Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters
B Sitter et al.
NMR IN BIOMEDICINE (2006)
Identification of magnetic resonance detectable metabolic changes associated with inhibition of phosphoinositide 3-kinase signaling in human breast cancer cells
M Beloueche-Babari et al.
MOLECULAR CANCER THERAPEUTICS (2006)
A pooled analysis of bone marrow micrometastasis in breast cancer
S Braun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
An integrated functional genomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancers
JE Ippolito et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition
ME Bollard et al.
NMR IN BIOMEDICINE (2005)
Population-based validation of the prognostic model ADJUVANT! for early breast cancer
IA Olivotto et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Circulating and disseminated tumor cells
S Braun et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence
W Janni et al.
CANCER (2005)
Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics
K Odunsi et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study
G Bonadonna et al.
BRITISH MEDICAL JOURNAL (2005)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases
J Yang et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2004)
Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterisation of xenobiotic toxicity and disease diagnosis
JL Griffin
CURRENT OPINION IN CHEMICAL BIOLOGY (2003)
Role of HER2 in wound-induced breast carcinoma proliferation
E Tagliabue et al.
LANCET (2003)
Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer
N Xenidis et al.
ANNALS OF ONCOLOGY (2003)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: Evaluation of their prognostic significance
A Stathopoulou et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Metabolic profiling of cell growth and death in cancer: applications in drug discovery
LG Boros et al.
DRUG DISCOVERY TODAY (2002)
Orthogonal projections to latent structures (O-PLS)
J Trygg et al.
JOURNAL OF CHEMOMETRICS (2002)
Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine-needle aspirates analysed using a statistical classification strategy
CE Mountford et al.
BRITISH JOURNAL OF SURGERY (2001)
Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer
PM Ravdin et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
